4//SEC Filing
Opexa Therapeutics, Inc. 4
Accession 0001140361-13-031305
CIK 0001069308operating
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 8:00 AM ET
Size
5.0 KB
Accession
0001140361-13-031305
Insider Transaction Report
Form 4
Radhakrishnan Karthik
Chief Financial Officer
Transactions
- Purchase
Common Stock
2013-08-08$1.50/sh+50,000$75,000→ 50,000 total
Footnotes (1)
- [F1]Purchased in an underwritten public offering which is expected to close on August 13, 2013.
Documents
Issuer
Opexa Therapeutics, Inc.
CIK 0001069308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001069308
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 8:00 AM ET
- Size
- 5.0 KB